What is she best known for?
The fields of study she is best known for:
- Alzheimer's disease
- Internal medicine
- Neuroscience
Her main research concerns Alzheimer's disease, Neuroscience, Pathology, Atrophy and Central nervous system disease.
Her Alzheimer's disease research includes elements of Neuroimaging and Dementia.
Pathology connects with themes related to Positron emission tomography in her study.
Her studies deal with areas such as Braak staging and Human brain as well as Positron emission tomography.
The subject of her Atrophy research is within the realm of Internal medicine.
In her study, Early-onset Alzheimer's disease, Cardiology, Cerebral atrophy, Age of onset and Fluorodeoxyglucose is strongly linked to Precuneus, which falls under the umbrella field of Central nervous system disease.
Her most cited work include:
- Episodic memory loss is related to hippocampal-mediated -amyloid deposition in elderly subjects (535 citations)
- PET Imaging of Tau Deposition in the Aging Human Brain (534 citations)
- Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease. (499 citations)
What are the main themes of her work throughout her whole career to date?
Suzanne L. Baker focuses on Neuroscience, Pathology, Disease, Amyloid and Internal medicine.
Many of her studies involve connections with topics such as Tau pathology and Neuroscience.
Her works in Alzheimer's disease, Atrophy, Posterior cortical atrophy, Frontotemporal lobar degeneration and Frontotemporal dementia are all subjects of inquiry into Pathology.
Her Alzheimer's disease research incorporates themes from Fluorodeoxyglucose, Positron emission tomography, Standardized uptake value and Central nervous system disease.
Her study in Internal medicine is interdisciplinary in nature, drawing from both Endocrinology, Oncology and Cardiology.
Her Cardiology research is multidisciplinary, incorporating elements of Early-onset Alzheimer's disease, Cerebral atrophy and Age of onset.
She most often published in these fields:
- Neuroscience (33.57%)
- Pathology (39.86%)
- Disease (32.87%)
What were the highlights of her more recent work (between 2019-2021)?
- Neuroscience (33.57%)
- Neuroimaging (13.29%)
- Disease (32.87%)
In recent papers she was focusing on the following fields of study:
Suzanne L. Baker mostly deals with Neuroscience, Neuroimaging, Disease, Pathology and Amyloid.
Her Neuroscience research includes themes of Tau pathology, Normal aging and Cognitive decline.
Her Disease research is multidisciplinary, incorporating perspectives in Clinical psychology and Cognition, Episodic memory.
In general Pathology, her work in Progressive supranuclear palsy is often linked to Neurofibrillary tangle linking many areas of study.
Her Amyloid study also includes fields such as
- Neurodegeneration together with Positron emission tomography,
- Beta, which have a strong connection to Brain aging.
Suzanne L. Baker focuses mostly in the field of Standardized uptake value, narrowing it down to matters related to Alzheimer's disease and, in some cases, Posterior cortical atrophy.
Between 2019 and 2021, her most popular works were:
- Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET (90 citations)
- Sleep Disturbance Forecasts β-Amyloid Accumulation across Subsequent Years. (12 citations)
- Spatial Relationships between Molecular Pathology and Neurodegeneration in the Alzheimer's Disease Continuum. (6 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Alzheimer's disease
- Neuroscience
Cognitive impairment, Standardized uptake value, Dementia, Pathology and Amyloid are her primary areas of study.
She interconnects Progressive supranuclear palsy, Corticobasal degeneration, Frontotemporal lobar degeneration, Frontotemporal dementia and Grey matter in the investigation of issues within Standardized uptake value.
Her Dementia research incorporates elements of Positron emission tomography and Neurodegeneration.
Suzanne L. Baker studied Positron emission tomography and Precision medicine that intersect with Internal medicine.
Her work on Neuropathology, Alzheimer's disease and Posterior cortical atrophy as part of general Pathology study is frequently linked to Neurofibrillary tangle and Association, therefore connecting diverse disciplines of science.
Her research in Amyloid intersects with topics in Executive functions, Asymptomatic, Cognitive test and Cognitive decline.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
